Statistics for Kymera Therapeutics, (id:6435 KYMR)

Valuation metrics

Market cap

3.24B

Enterprise value

2.78B

Trailing P/E (ttm)

-17.85

Forward P/E

-16.08

PEG ratio

-16.08

Price/Sales (ttm)

36.98

Price/Book (mrq)

3.63

Enterprise Value/Revenue

31.71

Enterprise Value/EBITDA

-14.58

Overview

Shares outstanding

64.77M

Float

43.99M

Shares short

9.07M

% Held by insiders

0.01%

% Held by institutions

1.06%

Average volume (10 days)

423.52K

Average volume (90 days)

Price summary

52-Week low

18.89

52-Week high

53.27

52-Week change

55.65%

Beta

2.22

50-Day moving average

47.13

200-Day moving average

40.43

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-191.26%

Operating margin

-1,927.93%

Operational effectiveness

Return on assets

-15.38%

Return on equity

-26.00%

Income statement

Revenue (ttm)

1.26

Revenue per share (ttm)

1.26

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-190,490,000.00

Net income to common (ttm)

-167,474,000.00

Diluted EPS (ttm)

-2.34

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

549.97M

Total cash per share (mrq)

8.49

Total debt (mrq)

88.23M

Total Debt/Equity (mrq)

9.88

Current ratio (mrq)

854.80%

Book value per share (mrq)

13.79

Cash flow

Cash flow statement

-124,672,000.00

Levered free cash flow (LFCF)

-94,098,128.00